GRI Bio, Inc. (GRI)
1.80
-0.03
(-1.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:31
GRI Bio Price : 1.80 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 1.88 | 1.971 | 1.720 | 1.83 | 56148.00 |
| Nov 10, 2026 | 1.85 | 1.91 | 1.75 | 1.89 | 57462.00 |
| Nov 09, 2026 | 1.84 | 1.88 | 1.71 | 1.71 | 37478.00 |
| Nov 06, 2026 | 1.56 | 1.940 | 1.56 | 1.88 | 43937.00 |
| Nov 05, 2026 | 1.42 | 1.67 | 1.42 | 1.55 | 128834.0 |
| Nov 04, 2026 | 1.53 | 1.54 | 1.36 | 1.43 | 48570.00 |
| Nov 03, 2026 | 1.47 | 1.552 | 1.42 | 1.54 | 52120.00 |
| Nov 02, 2026 | 1.52 | 1.56 | 1.46 | 1.46 | 12201.00 |
| Oct 30, 2026 | 1.59 | 1.59 | 1.45 | 1.53 | 28775.00 |
| Oct 29, 2026 | 1.60 | 1.65 | 1.57 | 1.57 | 23067.00 |
| Oct 28, 2026 | 1.57 | 1.660 | 1.563 | 1.625 | 7475.00 |
| Oct 27, 2026 | 1.51 | 1.629 | 1.487 | 1.58 | 33513.00 |
| Oct 26, 2026 | 1.47 | 1.52 | 1.440 | 1.50 | 11974.00 |
| Oct 23, 2026 | 1.45 | 1.53 | 1.422 | 1.45 | 65303.00 |
| Oct 22, 2026 | 1.46 | 1.47 | 1.385 | 1.42 | 102331.0 |
| Oct 21, 2026 | 1.58 | 1.58 | 1.46 | 1.47 | 58957.00 |
| Oct 20, 2026 | 1.45 | 1.538 | 1.45 | 1.46 | 46895.00 |
| Oct 19, 2026 | 1.37 | 1.50 | 1.36 | 1.45 | 42632.00 |
| Oct 16, 2026 | 1.485 | 1.560 | 1.370 | 1.38 | 51128.00 |
| Oct 15, 2026 | 1.43 | 1.45 | 1.38 | 1.40 | 28565.00 |
| Oct 14, 2026 | 1.54 | 1.56 | 1.40 | 1.40 | 51407.00 |
| Oct 13, 2026 | 1.60 | 1.60 | 1.52 | 1.55 | 35262.00 |
| Oct 12, 2026 | 1.75 | 1.75 | 1.550 | 1.57 | 64740.00 |
| Oct 09, 2026 | 1.71 | 1.76 | 1.700 | 1.74 | 21335.00 |
| Oct 08, 2026 | 1.85 | 1.88 | 1.68 | 1.68 | 54496.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.12 |
| Alnylam Pharmaceuticals, Inc. | 156.59 |
| Anika Therapeutics, Inc. | 13.84 |
| Savara, Inc. | 4.71 |
| Vericel Corp. | 57.40 |
Price Related Metrics
| Price to Book Value | 0.3828 |
| Earnings Yield | -2.43K% |
| Market Cap | 3.935M |